< alle items

Arvid van Oorschot and Otto Swens speakers at C5’s Life Sciences IP Summit in Munich, 16-17 October 2018

Geschreven door: Vondst Newsdesk

2 oktober 2018

On 16 and 17 October, the 5th annual edition of C5’s Life Sciences IP Summit will take place in Munich. Alongside the latest legal information and challenges assessment for Pharmaceutical and Biotech companies, the event will also address the legal environment for Medical Device companies.

C5’s Life Sciences IP Summit sets the scene for the future of SPCs in Europe, provides a deeper understanding of secondary medical use patents and gives practical insights on how an in-house counsel should manage patent litigation from beginning to end. The event provides comprehensive knowledge and benchmarking opportunities to ensure that attendees can lead the way in patent protection.

Arvid van Oorschot leads the panel session “Secondary Medical Use: Developing Strategies for Enforcement”, whilst Otto Swens moderates the session “Doctrine of Equivalence: Understanding how the latest decisions will impact patenting law in the UK, U.S., Germany and Netherlands”.

For more information visit C5’s website.